GENERAL

Implantable Vision, Inc. is a development-stage company that is developing, and intends to commercialize, phakic intraocular lenses (i.e., inside the eye contact lenses) to capture a portion of the refractive surgical vision correction market. Unless the context indicates otherwise, references in this report to "we," "us," and "our company" refer to Implantable Vision, Inc. and its consolidated subsidiaries.

Consumer acceptance of surgical vision correction has increased dramatically over the past decade. While the market for surgical vision correction was relatively inconsequential ten years ago, the market has attained annual worldwide...